United States

People: Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

4:00pm EDT
Change (% chg)

$0.43 (+2.77%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Aghazadeh, Behzad 

Dr. Behzad Aghazadeh is Independent Chairman of the Board of the Company, since March 2017. He is a Managing Partner and Portfolio Manager of the venBio Select Fund. He brings more than 20 years of experience in the biopharmaceutical industry, including more than 10 years as an institutional investor and previously six years at Booz Allen as a general management consultant to senior executive teams in the healthcare sector.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --